Normalization of platelet reactivity in clopidogrel-treated subjects
about
Management of bleeding and coagulopathy following major trauma: an updated European guideline.Clinical review: Traumatic brain injury in patients receiving antiplatelet medicationTicagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An UpdateThe European guideline on management of major bleeding and coagulopathy following trauma: fourth editionClopidogrel and hip fractures, is it safe? A systematic review and meta-analysisAlternatives to allogeneic platelet transfusion.Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression.Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.Proposal for the Rapid Reversal of Coagulopathy in Patients with Nonoperative Head Injuries on Anticoagulants and/or Antiplatelet Agents: A Case Study and Literature Review.Management of anticoagulation before and after gastrointestinal endoscopy.Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update.Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents.How do I transfuse platelets (PLTs) to reverse anti-PLT drug effect?Pathophysiology of Cardiopulmonary Bypass: Current Strategies for the Prevention and Treatment of Anemia, Coagulopathy, and Organ Dysfunction.Platelet function inhibitors and platelet function testing in neurointerventional procedures.Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature.Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor.Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitorsThe aspirin story - from willow to wonder drug.Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets.Effects of autologous platelet transfusion on platelet inhibition in ticagrelor-treated and clopidogrel-treated subjects.A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats.The Role of Platelet Function Analyzer Testing in Cardiac Surgery Transfusion Management.Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study.Antiplatelet drugs in elective ENT surgery.Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue.Peri-operative management of anticoagulation and antiplatelet therapy.Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model.Intravenous administration of tirofiban versus loading dose of oral clopidogrel for preventing thromboembolism in stent-assisted coiling of intracranial aneurysms.Critical care neurology: Five new things.Perioperative management of the bleeding patient.Safety and efficacy of a new prophylactic tirofiban protocol without oral intraoperative antiplatelet therapy for endovascular treatment of ruptured intracranial aneurysms.High prevalence of pharmacologically induced platelet dysfunction in the acute setting of brain injury.
P2860
Q21092902-ABC0EEDC-BC4B-4B41-91BB-12476ADDEEFCQ26830409-4A3B08A3-C3CD-4D39-A1AF-345D2401FBB6Q27006031-1A32E4B6-B0D7-40B1-85B5-7E5B93241A18Q27339343-C2DA1FE5-DD0A-4BAB-893D-95D8294D9D32Q28068229-B566B72A-B26D-48FA-9666-2223710EC4DDQ33435484-42B07490-A897-412D-834B-B1737EA4068CQ33953523-949C5DB3-4C30-4F9C-8DE0-356CB6BFC1D6Q34716730-1043D188-2C59-4123-B817-B30B9CD17FEDQ36331578-AEB68595-C645-4F33-AFCF-5B903747E64FQ37578257-258AFA0A-5889-45C3-9955-0E659A54E0B2Q37801291-BBC661DB-55F4-486C-9D52-96F62B5302D6Q37897674-989F2E4E-1EA3-4618-AD62-E6DF34AEA4BDQ37919935-C01655E9-A230-4DAF-9335-419C92D3A8F1Q38215982-70E86C7F-EA10-4C59-B39B-0B2765B716AEQ38233284-654D9692-4E45-4C30-8997-E001D0D5F51BQ38285960-005E5B5E-F64A-403D-8241-FEDEBF6D9478Q38372841-8C24CD9B-57A9-4D02-860E-B39F0B9B0197Q38631422-9F3C7936-449A-4293-84EC-B9F3121803AFQ38768065-DDBD11F2-953B-4107-9864-7F181BE232B7Q39044618-CE909474-843C-4968-AC18-0D4DE8E1A885Q39366233-61B52746-A8CB-4F82-BD38-28D6CC8CAD8EQ39989728-59CBC4F0-328D-47BC-8837-366AE4EA87ECQ40201873-AC561AA7-1D99-4FCC-B6D2-DB0522278106Q41023511-F9B3F2F7-E80B-4260-9CAF-444DF2BA5F4CQ43839301-AC70D5C6-7B65-406C-A435-2AE85D0F5F23Q45276265-7F81E772-7AD2-485B-807D-C25A0228E8D9Q48219571-2EB196D0-FF4F-4B4C-ADAD-DE8DB2170CACQ48316287-7D4E3AE0-C089-4B01-AF10-538F2EF8335DQ48686943-E81ACF71-DCF1-41E5-AFA2-77AB3A013649Q48724831-6EA27EB4-2DEE-40B1-A056-EED7B571AFF4Q50007023-B7A4509F-31E5-4983-94A6-C12C56553E0DQ50312912-C025F34B-FD9F-4917-AD94-190C93CBADE4Q51626769-C8B9CBBE-4864-4C19-8C3C-69263ECE11CDQ52145832-9CC3863D-B502-48E3-8F26-25C54FAD266E
P2860
Normalization of platelet reactivity in clopidogrel-treated subjects
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Normalization of platelet reactivity in clopidogrel-treated subjects
@ast
Normalization of platelet reactivity in clopidogrel-treated subjects
@en
Normalization of platelet reactivity in clopidogrel-treated subjects
@nl
type
label
Normalization of platelet reactivity in clopidogrel-treated subjects
@ast
Normalization of platelet reactivity in clopidogrel-treated subjects
@en
Normalization of platelet reactivity in clopidogrel-treated subjects
@nl
prefLabel
Normalization of platelet reactivity in clopidogrel-treated subjects
@ast
Normalization of platelet reactivity in clopidogrel-treated subjects
@en
Normalization of platelet reactivity in clopidogrel-treated subjects
@nl
P2093
P2860
P3181
P1476
Normalization of platelet reactivity in clopidogrel-treated subjects
@en
P2093
D A Vorchheimer
J F Viles-Gonzalez
J J Badimon
P2860
P3181
P356
10.1111/J.1538-7836.2006.02245.X
P407
P577
2007-01-01T00:00:00Z